BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jörling M, Rutzner S, Hecht M, Fietkau R, Distel LV. Deterioration of Health-Related Quality of Life Scores under Treatment Predicts Longer Survival. Biomed Res Int 2020;2020:3565238. [PMID: 32879881 DOI: 10.1155/2020/3565238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sher DJ, Radpour S, Shah JL, Pham NL, Jiang S, Vo D, Sumer BD, Day AT. Pilot Study of a Wearable Activity Monitor During Head and Neck Radiotherapy to Predict Clinical Outcomes. JCO Clin Cancer Inform 2022;6:e2100179. [PMID: 35333597 DOI: 10.1200/CCI.21.00179] [Reference Citation Analysis]
2 Campanacci L, Cevolani L, De Terlizzi F, Saenz L, Alì N, Bianchi G, Donati DM. Electrochemotherapy Is Effective in the Treatment of Bone Metastases. Current Oncology 2022;29:1672-82. [DOI: 10.3390/curroncol29030139] [Reference Citation Analysis]
3 Griewing LM, Schweizer C, Schubert P, Rutzner S, Eckstein M, Frey B, Haderlein M, Weissmann T, Semrau S, Gostian AO, Müller SK, Traxdorf M, Iro H, Zhou JG, Gaipl US, Fietkau R, Hecht M. Questionnaire-based detection of immune-related adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors. BMC Cancer 2021;21:314. [PMID: 33761922 DOI: 10.1186/s12885-021-08006-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Frank F, Hecht M, Loy F, Rutzner S, Fietkau R, Distel L. Differences in and Prognostic Value of Quality of Life Data in Rectal Cancer Patients with and without Distant Metastases. Healthcare (Basel) 2020;9:E1. [PMID: 33374955 DOI: 10.3390/healthcare9010001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]